Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.560 -0.010 (-0.64%)
Streaming Delayed Price Updated: 1:13 PM EDT, Aug 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,918,397
Open 1.580
Bid (Size) 1.550 (70,100)
Ask (Size) 1.560 (74,200)
Prev. Close 1.570
Today's Range 1.550 - 1.600
52wk Range 1.040 - 2.010
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Geron (GERN) Q2 2026 Earnings Call Transcript ↗
RYTELO demand grew 5% as prescribing accounts hit 1,575 since launch. 
Via The Motley Fool
Topics Earnings
News headline image
Geron Q2 Earnings Call Highlights ↗
Geron (NASDAQ:GERN) reported second-quarter net revenue of $57.5 million, up 17% from a year earlier and 11% sequentially, as the company continued to expand use of RYTELO among patients with... 
Via MarketBeat
Topics Earnings

Performance

YTD
+18.2%
+18.2%
1 Month
+9.9%
+9.9%
3 Month
+10.6%
+10.6%
6 Month
-3.1%
-3.1%
1 Year
+15.6%
+15.6%

More News

Read More
Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected ↗
Via Chartmill
News headline image
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
Via FinancialNewsMedia
Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues ↗
Via Chartmill
Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Geron Earnings Preview ↗
Via Benzinga
News headline image
Geron (GERN) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy
News headline image
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
Via FinancialNewsMedia
Here are the top movers in Wednesday's session. ↗
Via Chartmill
News headline image
Geron (GERN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Which stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
Via Chartmill
News headline image
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
From Geron Corporation
Via Business Wire
News headline image
Geron Corporation to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
News headline image
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
From Geron Corporation
Via Business Wire
News headline image
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
From Geron Corporation
Via Business Wire
News headline image
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
News headline image
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
From Geron Corporation
Via Business Wire
News headline image
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
News headline image
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.560
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 08/13/26 01:13 PM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 793.68M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 794M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.